(OTC: KKUR) Leading the Way in Cancer Detection and Cure
February 03 2010 - 9:15AM
Marketwired
ChromoCure, Inc. (PINKSHEETS: KKUR) announced yesterday that they
have kicked off their newest research initiative, "Project Boveri:
Find the Cure."
The recent pledge made by President Obama stating that we will
cure cancer "in our time" has put more attention on cancer research
than ever before. ChromoCure has championed the
chromosomal/aneuploidy theory of cancer which has been corroborated
in recent Medical findings by third party research publications
including the Mayo Clinic.
ChromoCure is reaching out to collaborate with others to expand
its research into detecting cancer in its earliest stages, greatly
aiding the ability to cure it. ChromoCure, and its proprietary
ChromoSomal detection technology can detect cancer 100% of the time
at every stage of cancer development.
For more information, please visit: www.chromocure.com
Other active stocks are International Stem Cell Corp (OTCBB:
ISCO) MedCath Corp (NASDAQ: MDTH) and Select Medical Holdings
(NYSE: SEM)
Information, opinions and analysis contained herein are based on
sources believed to be reliable, but no representation, expressed
or implied, is made as to its accuracy, completeness or
correctness. The opinions contained herein reflect our current
judgment and are subject to change without notice. We accept no
liability for any losses arising from an investor's reliance on or
use of this report. This report is for information purposes only,
and is neither a solicitation to buy nor an offer to sell
securities. A third party has hired and paid IO News Wire twelve
hundred and ninety five dollars for the publication and circulation
of this news release. Certain information included herein is
forward-looking within the meaning of the Private Securities
Litigation Reform Act of 1995, including, but not limited to,
statements concerning manufacturing, marketing, growth, and
expansion. Such forward-looking information involves important
risks and uncertainties that could affect actual results and cause
them to differ materially from expectations expressed herein. We
have no ownership of equity, no representation; do no trading of
any kind and send no faxes or emails.
Contact: Eric Jensen www.ionewswire.com 516.942.4910
Chromocure (CE) (USOTC:KKUR)
Historical Stock Chart
From Jul 2024 to Aug 2024
Chromocure (CE) (USOTC:KKUR)
Historical Stock Chart
From Aug 2023 to Aug 2024